Is there evidence supporting the use of topical povidone‑iodine and tea‑tree oil for treatment of molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Molluscum Contagiosum with Topical Iodine and Tea Tree Oil

The combination of tea tree oil with iodine (TTO-I) shows beneficial evidence for treating molluscum contagiosum in children, with a >90% lesion reduction in 84% of treated patients, while either agent alone is significantly less effective. 1

Evidence for the Combination Therapy

The strongest evidence comes from a randomized controlled trial of 53 children (mean age 6.3 years) comparing three topical treatments applied twice daily for 30 days 1:

  • TTO-I combination: 16 of 19 children (84%) achieved >90% lesion reduction
  • Iodine alone: Only 1 of 16 children (6%) achieved the same outcome
  • Tea tree oil alone: Only 3 of 18 children (17%) achieved the same outcome
  • Statistical significance: P<0.01

This represents a dramatic synergistic effect—the combination is far superior to either component used individually.

Supporting Evidence

Additional case series data supports povidone-iodine preparations:

  • A 2017 case series of 12 pediatric patients using dilute povidone-iodine showed 90% of lesions (103/115) resolved, with 67% achieving complete clearance 2
  • A 2016 case report demonstrated effectiveness of povidone-iodine/dimethylsulfoxide combination 3

A 2023 systematic review of tea tree oil applications noted that "tea tree oil with added iodine may provide an effective treatment for molluscum contagiosum lesions in young children" 4, though it acknowledged the limited evidence base.

Context Within Treatment Landscape

Important caveat: The 2017 Cochrane review on molluscum contagiosum interventions found that "no single intervention has been shown to be convincingly effective" and noted that "natural resolution of molluscum contagiosum remains a strong method for dealing with the condition" 5. However, this review predated some of the povidone-iodine case series data and the TTO-I combination study was included but represented one of the few positive findings.

The Cochrane review did identify the TTO-I combination as showing benefit (RR for iodine plus tea tree oil vs. tea tree oil alone: 0.20,95% CI 0.07 to 0.57; and vs. iodine alone: 0.07,95% CI 0.01 to 0.50) 5.

Safety Profile

  • No serious adverse effects were reported in any of the studies 1, 2
  • Treatment was well-tolerated with minimal side effects
  • No children discontinued treatment due to adverse events 1
  • Povidone-iodine FDA labeling indicates it is for external use only and should not be used longer than 1 week unless directed by a physician 6

Clinical Application

For pediatric molluscum contagiosum, use the combination of tea tree oil with organically bound iodine applied topically twice daily. Expect to see significant improvement within 30 days. This approach offers a non-invasive alternative to destructive methods like cryotherapy or curettage, which can be frightening and painful for children.

Monitor for local skin irritation and discontinue if significant redness, swelling, or pain develops 6. The combination therapy appears to work through complementary antimicrobial mechanisms that neither agent achieves alone.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.